4Sc AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 4Sc AG with three other
pharmaceutical manufacturers in Europe:
Enzymatica AB (publ)
sales of 27.91 million Swedish Kronor [US$3.16 million]
(3.48 million Euro [US$3.82 million]
of which 88%
was Orphan Products Oncology), and
based in Norway
(31.69 million Norwegian Kroner [US$3.90 million]
of which 100%
was Vitamin K2/MenaQ7).
4Sc AG reported sales of 3.27 million Euro (US$3.59 million)
December of 2015.
decrease of 53.7%
versus 2014, when the company's sales were 7.06 million Euro.
Contributing to the drop in overall sales was the 70.4% decline
in Collaborative Business, from 3.28 million Euro to 970,000.00 Euro.
There were also decreases in sales in
Drug Discovery and Development (down 39.2% to 2.30 million Euro)